198 related articles for article (PubMed ID: 18691571)
1. A novel cell transplantation protocol and its application to an ALS mouse model.
Morita E; Watanabe Y; Ishimoto M; Nakano T; Kitayama M; Yasui K; Fukada Y; Doi K; Karunaratne A; Murrell WG; Sutharsan R; Mackay-Sim A; Hata Y; Nakashima K
Exp Neurol; 2008 Oct; 213(2):431-8. PubMed ID: 18691571
[TBL] [Abstract][Full Text] [Related]
2. [Effect of transplantation of wild-type bone marrow stem cells in mouse model of familial amyotrophic lateral sclerosis].
Huang H; Zhang C; Zhao CP; Yao XL; Xi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):562-6. PubMed ID: 16995314
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cells LewisX+ CXCR4+ modify disease progression in an amyotrophic lateral sclerosis model.
Corti S; Locatelli F; Papadimitriou D; Del Bo R; Nizzardo M; Nardini M; Donadoni C; Salani S; Fortunato F; Strazzer S; Bresolin N; Comi GP
Brain; 2007 May; 130(Pt 5):1289-305. PubMed ID: 17439986
[TBL] [Abstract][Full Text] [Related]
4. Is it too soon for mesenchymal stem cell trials in people with ALS?
Badayan I; Cudkowicz ME
Amyotroph Lateral Scler; 2008 Dec; 9(6):321-2. PubMed ID: 18819027
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
[TBL] [Abstract][Full Text] [Related]
6. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.
Chen L; Huang H; Zhang J; Zhang F; Liu Y; Xi H; Wang H; Gu Z; Song Y; Li Y; Tan K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):961-6. PubMed ID: 17933231
[TBL] [Abstract][Full Text] [Related]
7. Stem cell treatment in Amyotrophic Lateral Sclerosis.
Mazzini L; Mareschi K; Ferrero I; Vassallo E; Oliveri G; Nasuelli N; Oggioni GD; Testa L; Fagioli F
J Neurol Sci; 2008 Feb; 265(1-2):78-83. PubMed ID: 17582439
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
[TBL] [Abstract][Full Text] [Related]
9. Stem therapy for ALS: hope and reality.
Silani V; Leigh N
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Apr; 4(1):8-10. PubMed ID: 12745611
[TBL] [Abstract][Full Text] [Related]
10. Culturing olfactory ensheathing cells from the mouse olfactory epithelium.
Richter M; Westendorf K; Roskams AJ
Methods Mol Biol; 2008; 438():95-102. PubMed ID: 18369752
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration.
Zhang ZL; Tong J; Lu RN; Scutt AM; Goltzman D; Miao DS
Bone Marrow Transplant; 2009 Jan; 43(1):69-81. PubMed ID: 18711348
[TBL] [Abstract][Full Text] [Related]
12. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice.
Tanaka K; Okada Y; Kanno T; Otomo A; Yanagisawa Y; Shouguchi-Miyata J; Suga E; Kohiki E; Onoe K; Osuga H; Aoki M; Hadano S; Itoyama Y; Ikeda JE
Exp Neurol; 2008 Jun; 211(2):378-86. PubMed ID: 18423451
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy.
Rizvanov AA; Kiyasov AP; Gaziziov IM; Yilmaz TS; Kaligin MS; Andreeva DI; Shafigullina AK; Guseva DS; Kiselev SL; Matin K; Palotás A; Islamov RR
Neurochem Int; 2008 Dec; 53(6-8):389-94. PubMed ID: 18948156
[TBL] [Abstract][Full Text] [Related]
14. Enhanced survival of bone-marrow-derived pluripotent stem cells in an animal model of auditory neuropathy.
Matsuoka AJ; Kondo T; Miyamoto RT; Hashino E
Laryngoscope; 2007 Sep; 117(9):1629-35. PubMed ID: 17632425
[TBL] [Abstract][Full Text] [Related]
15. Survival and migration of human and rat olfactory ensheathing cells in intact and injured spinal cord.
Deng C; Gorrie C; Hayward I; Elston B; Venn M; Mackay-Sim A; Waite P
J Neurosci Res; 2006 May; 83(7):1201-12. PubMed ID: 16498634
[TBL] [Abstract][Full Text] [Related]
16. Fetal olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients: a controlled pilot study.
Huang H; Chen L; Xi H; Wang H; Zhang J; Zhang F; Liu Y
Clin Transplant; 2008; 22(6):710-8. PubMed ID: 18673377
[TBL] [Abstract][Full Text] [Related]
17. Distribution, differentiation, and survival of intravenously administered neural stem cells in a rat model of amyotrophic lateral sclerosis.
Mitrecić D; Nicaise C; Gajović S; Pochet R
Cell Transplant; 2010; 19(5):537-48. PubMed ID: 20350352
[TBL] [Abstract][Full Text] [Related]
18. Undesired effects of a combinatorial treatment for spinal cord injury--transplantation of olfactory ensheathing cells and BDNF infusion to the red nucleus.
Bretzner F; Liu J; Currie E; Roskams AJ; Tetzlaff W
Eur J Neurosci; 2008 Nov; 28(9):1795-807. PubMed ID: 18973595
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
[TBL] [Abstract][Full Text] [Related]
20. [Olfactory ensheathing cells transplantation for central nervous system diseases in 1,255 patients].
Huang H; Chen L; Xi H; Wang Q; Zhang J; Liu Y; Zhang F
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2009 Jan; 23(1):14-20. PubMed ID: 19192871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
